Acknowledgement for APICES collaboration in study Geminis published in «Hematology«

This month, we want to share the acknowledgment that APICES has received in the recent publication titled “A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the Geminis study”, published in Hematology in which APICES has collaborated in study setup, coordination and project management, monitoring, data management, statistical analysis and manuscript.…

Acknowledgement for APICES collaboration in VERNE study published in «Digestive and Live Disease»

We are privileged to share the acknowledgment that APICES has received in the recent publication titled: “Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE study”, a study in which APICES has participated in study setup, design, monitoring, data management, statistics…

Acknowledgment for APICES collaboration in TIME study published in “Expert Opinion on Pharmacotherapy”

We are privileged to share the acknowledgment that APICES has received in the recent publication titled: “Impact on functionality of the paliperidone palmitate three-month formulation in patients with a recent diagnosis of schizophrenia: a real-world observational prospective study”, published in Expert Opinion on Pharmacotherapy, a study in which APICES has participated in study setup, project…

GESTO platform: Publication of results of observational studies with medicinal products for human use

After approval of the RD 957/2020 which regulates observational studies with medicinal products for human use it is mandatory the publication of results of observational studies with medicinal products for human use in the spanish clinical trials registry, as we mentioned in a previous post. Thus, the AEMPS with the aim to facilitate this process…

New regulation for observational studies with medicines for human use in Spain

Last week, the Royal Decree 957/2020 which regulates the observational studies with medicines for human use was published in the BOE. This regulation will come into force on January 2, 2021 aims to simplify the procedures regulated by the Order SAS/3470/2009 taking into account the observational nature of these type of studies with drugs that…